Latent Tuberculosis: A Promising New Compound to Treat Non-Replicating and Intramacrophagic Mycobacteria

Latent Tuberculosis: A Promising New Compound to Treat Non-Replicating and Intramacrophagic Mycobacteria

As a biologic reservoir of <i>Mycobacterium tuberculosis</i> (<i>M. tb</i>), one-quarter of the world population is infected with the well-known latent tuberculosis (LTBI). About 5–10% of LTBI patients will progress to active disease in the first years after primary infection...

Full description

Bibliographic Details
Main Authors: Débora Leite Campos, Fernanda Manaia Demarqui, Mariana Cristina Solcia, Paula Carolina de Souza, Pedro Ivo da Silva Maia, Victor Marcelo Deflon, Fernando Rogério Pavan
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Biomedicines
Subjects:
latent tuberculosis
<i>Mycobacterium tuberculosis</i>
treatment
Online Access:https://www.mdpi.com/2227-9059/10/10/2398

Similar Items

Similar Items